ArticleBMC pulmonary medicine2026
Risk factors for nontuberculous mycobacteria infection in lung transplant recipients.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundThe incidence and number of deaths of nontuberculous mycobacteria (NTM) infection in lung transplant recipients is on the rise. Risk factors for NTM infection after lung transplant are not well characterized.
methodsThis was a retrospective, single-center case-control study including patients who underwent lung transplantation (LTx) at the China-Japan Friendship Hospital between March 2018 and April 2024. A total of 23 NTM infection patients and 474 controls were enrolled in the study. Cox regression analysis and competing risks models were used to identify risk factors for NTM infection after LTx.
resultsThe incidence of antibody-mediated rejection (AMR) (26.1% versus 8.2%; p value = 0.012) was higher in the NTM infection group than in controls. A 1:2 propensity score matching resulted in 18 NTM infection patients and 36 controls. The incidence of AMR in NTM infection group remained higher than in controls. Univariable Cox regression analysis revealed that the occurrence of AMR (hazard ratio [HR]5.77; 95% confidence interval [CI] 1.45-23.00; p value = 0.013) and CLAD (HR 3.40; 95% CI 1.03-11.19; p value = 0.044) were risk factors for NTM infection. Adjusted multivariable Cox regression analysis demonstrated that the occurrence of AMR was independently associated with increased risk of NTM infection. Competitive risk models showed that LTRs with AMR had a substantially higher cumulative incidence of NTM infection.
conclusionsOur findings suggest a possible association between AMR and NTM infection. In addition, this study provides clinicians with relevant information regarding NTM infection in this setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.